Fetal genetic score for birth weight affects fetal growth at various maternal fasting plasma glucose levels.
This study demonstrated the importance of early screening and diagnosis of type 2 diabetes in mothers and their offspring.
Investigators developed a community-based pre-pregnancy care program to improve pregnancy outcomes.
Greater awareness of clinical and cost implications of gaps for patients with lower-severity gestational diabetes may improve postdelivery testing and referral.
A tailored electronic health record letter may improve gestational weight gain and reduce postpartum weight retention.
The researchers found that, compared with women without gestational diabetes or subsequent diabetes, women with a history of gestational diabetes had significantly higher estimated glomerular filtration rate.
Findings do not support noninferiority of glyburide for prevention of perinatal complications of gestational diabetes.
Results showed there was a significant crude risk linked to continuing vs discontinuing certain antipsychotics and developing gestational diabetes; for quetiapine the risk was 7.1% vs 4.1% (adjusted relative risk [ARR] 1.28), respectively; among olanzapine users it was 12% vs 4.7% (ARR 1.61), respectively.
Routine screening for neonatal hypoglycemia after pregnancies complicated by gestational diabetes (GD) reveals high incidence of both mild and severe hypoglycemia for both diet-controlled and insulin-treated GD and across the full range of birth weight centiles.
In this randomized controlled trial, glyburide was not noninferior in terms of the composite rate of macrosomia, neonatal hypoglycemia, and hyperbilirubinemia compared with subcutaneous insulin.
Researchers assessed the associations of pre-pregnancy fitness, moderate-to-vigorous-intensity physical activity, and time spent watching television on subsequent development of gestational diabetes.
Parents and healthcare workers should carefully consider the risk for obesity in infants born to women with diabetes, especially infants born large for gestational age, and should initiate preventive measures where possible.
For women with previous gestational diabetes, lactation is associated with reduced risk of type 2 diabetes, although there is no benefit for long-term lactation.
High-quality studies are needed to determine whether tight intrapartum glycemic control is superior to more relaxed glycemic targets intrapartum for women with diabetes in pregnancy.
Ten randomized controlled trials were examined to determine the efficacy and safety of glyburide vs insulin treatment for gestational diabetes.
Hyperandrogenic PCOS is associated with maternal pregnancy complications, including gestational diabetes.
Special considerations are needed when treating women of reproductive age with pregestational diabetes.
Researchers examined the relationship between maternal diabetes and asthma risk in children.
Neonates did not differ in terms of birthweight, fat mass, body fat percentage, and sum of skinfolds, regardless of treatment.
One biomarker measurement during pregnancy can identify glucose intolerance with high sensitivity and specificity.
Women who required insulin for gestational diabetes had an increased risk of developing postpartum diabetes.
Gestational diabetes had a 23.3% incidence rate in the combination inositol group compared with 18.3% in the control group.
Pregnant women who took lactobacillus rhamnosus HN001 in their second trimester had lower rates of gestational diabetes.
No difference in incidence of gestational diabetes was noted between those who took inositol supplements vs those who did not.
For patients with gestational diabetes, glyburide and metformin are comparable in terms of glucose control and safety.
Women who were pregnant and slept for less than 6 hours per night or had poor sleep quality had a greater risk of developing gestational diabetes.
The risk of cardiovascular outcomes is elevated for women with gestational diabetes, even in the absence of subsequent type 2 diabetes.
Higher iron stores in the body may increase risk for gestational diabetes.
Early second trimester lipids can identify maternal gestational diabetes, according to a study published in Diabetes Care.
For women with a history of gestational diabetes, having more health visits in the previous year is associated with receiving diabetes screening.
Endocrinology Advisor Articles
- Subclinical Hypothyroidism: Controversies in Testing and Treatment
- Favorable Outcomes With Second-Generation Insulin Analogs in Type 2 Diabetes
- Fatigue Management Contributes to Effective Endometriosis Care
- Assessment of Low-Dose Aspirin As Chemoprevention in Type 2 Diabetes
- Treatment With Alemtuzumab May Frequently Induce Thyroid Dysfunction
- Using Latent Class Trajectory Analysis to Determine Glucose Response Curve Patterns
- First CGM System With Implantable Glucose Sensor Approved
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
- Two Phases of C-Peptide Decline Identified in Type I Diabetes
- Risk for Hypoglycemia During Titration With Insulin Glargine 100 U/mL in T2D
- Trulicity Labeling Updated to Include Data on T2D Patients With CKD
- New Data Support Long-Term Cardiovascular Safety of Linagliptin in T2D
- Peer-Led Education Helps Physicians Save Time With EHRs
- As Immigration Policies Tighten, Physician Shortage Concerns Grow